Redcare Pharmacy NV (XSWX:RDC) Cyclically Adjusted Revenue per Share: CHF64.49 (As of Mar. 2026)


XSWX:RDC Redcare Pharmacy NV XSWX:RDC
48 GF Score
Price CHF60.95
GF Value CHF143.20
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Redcare Pharmacy NV Cyclically Adjusted Revenue per Share?

Redcare Pharmacy NV XSWX:RDC 48 Cyclically Adjusted Revenue per Share is CHF64.49 as of Mar. 2026. GuruFocus rates XSWX:RDC with a GF Score™ of 48/100 and a GF Value™ of CHF143.20 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Redcare Pharmacy NV's adjusted revenue per share for the three months ended in Mar. 2026 was CHF38.444. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is CHF64.49 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Redcare Pharmacy NV's average Cyclically Adjusted Revenue Growth Rate was 18.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-06-27), Redcare Pharmacy NV's current stock price is CHF60.95. Redcare Pharmacy NV's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was CHF64.49. Redcare Pharmacy NV's Cyclically Adjusted PS Ratio of today is 0.95.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Redcare Pharmacy NV was 2.03. The lowest was 0.39. And the median was 1.07.


Redcare Pharmacy NV  (XSWX:RDC) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Redcare Pharmacy NV's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=60.95/64.49
=0.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Redcare Pharmacy NV was 2.03. The lowest was 0.39. And the median was 1.07.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Redcare Pharmacy NV Cyclically Adjusted Revenue per Share Related Terms


Redcare Pharmacy NV Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Redcare Pharmacy NV's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redcare Pharmacy NV Cyclically Adjusted Revenue per Share Chart

Redcare Pharmacy NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Redcare Pharmacy NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 64.49

Redcare Pharmacy NV Cyclically Adjusted Revenue per Share Competitor Comparison

For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redcare Pharmacy NV Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Redcare Pharmacy NV's Cyclically Adjusted PS Ratio falls into.


XSWX:RDC
48GF Score
Redcare Pharmacy NV XSWX:RDC
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redcare Pharmacy NV Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Redcare Pharmacy NV's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=38.444/135.2700*135.2700
=38.444

Current CPI (Mar. 2026) = 135.2700.

Redcare Pharmacy NV Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 4.942 100.260 6.668
201609 5.121 100.570 6.888
201612 6.248 100.710 8.392
201703 7.532 101.440 10.044
201706 7.547 101.370 10.071
201709 8.153 102.030 10.809
201712 9.020 101.970 11.966
201803 12.707 102.470 16.774
201806 12.178 103.100 15.978
201809 12.281 103.950 15.981
201812 14.133 103.970 18.388
201903 16.351 105.370 20.991
201906 14.389 105.840 18.390
201909 13.846 106.700 17.553
201912 15.557 106.800 19.704
202003 18.264 106.850 23.122
202006 17.827 107.510 22.430
202009 14.341 107.880 17.982
202012 15.952 107.850 20.008
202103 17.526 108.870 21.776
202106 15.134 109.670 18.667
202109 14.271 110.790 17.424
202112 16.565 114.010 19.654
202203 17.240 119.460 19.522
202206 16.192 119.050 18.398
202209 15.066 126.890 16.061
202212 17.777 124.940 19.247
202303 20.257 124.720 21.971
202306 21.895 125.830 23.538
202309 22.958 127.160 24.422
202312 25.199 126.450 26.957
202403 27.022 128.580 28.428
202406 26.939 129.910 28.050
202409 26.871 131.610 27.618
202412 31.352 131.630 32.219
202503 34.081 133.330 34.577
202506 33.075 133.960 33.398
202509 33.415 135.920 33.255
202512 36.895 135.270 36.895
202603 38.444 135.270 38.444

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of CHF64.49 mean?
Redcare Pharmacy NV (XSWX:RDC) has a Cyclically Adjusted Revenue per Share of CHF64.49 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Redcare Pharmacy NV and its competitors.
Is Redcare Pharmacy NV's Cyclically Adjusted Revenue per Share too high?
Redcare Pharmacy NV's current Cyclically Adjusted Revenue per Share is CHF64.49. Overall, Redcare Pharmacy NV has a GF Score™ of 48/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's Cyclically Adjusted Revenue per Share compare to competitors?
Redcare Pharmacy NV's Cyclically Adjusted Revenue per Share of CHF64.49 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Redcare Pharmacy NV and its competitors. Redcare Pharmacy NV's current Cyclically Adjusted Revenue per Share is CHF64.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (XSWX:RDC) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF143.20, compared to a current price of CHF60.95 — trading 57.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is CHF64.49. Redcare Pharmacy NV's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Redcare Pharmacy NV (XSWX:RDC), the current Cyclically Adjusted Revenue per Share is CHF64.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Redcare Pharmacy NV (XSWX:RDC) Overvalued in 2026?

Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued. The current stock price of CHF60.95 is trading 57.4% below its estimated GF Value™ of CHF143.20. GuruFocus considers Redcare Pharmacy NV to be Significantly Undervalued.

Key valuation signals for XSWX:RDC:

  • Cyclically Adjusted Revenue per Share: CHF64.49
  • GF Value™: CHF143.20 vs. price of CHF60.95 (57.4% below fair value)
  • GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the XSWX:RDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Redcare Pharmacy NV Business Description

Address Erik de Rodeweg 11/13, Sevenum, ZH, NLD, 5975 WD
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
48GF Score

Get the complete analysis for XSWX:RDC

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF60.95
Price
CHF143.20
GF Value